Stephanie Bjerrum1,2, Joseph Oliver-Commey3, Ernest Kenu3, Margaret Lartey3, Mercy Jemima Newman4, Kennedy Kwasi Addo5, Doris Hilleman6, Aase Bengaard Andersen2,7, Isik Somuncu Johansen1. 1. Department of Infectious Diseases, Odense University Hospital, Odense, Denmark. 2. Institute of Clinical Research, University of Southern Denmark, Odense, Denmark. 3. Fevers Unit, Department of Medicine, Korle-Bu Teaching Hospital, Accra, Ghana. 4. Department of Medical Microbiology, University of Ghana, Accra, Ghana. 5. Department of Bacteriology, University of Ghana, Accra, Ghana. 6. National Reference Centre for Mycobacteria, Research Centre Borstel, Sülfeld, Germany. 7. Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.
Abstract
OBJECTIVES: To assess the prevalence and clinical importance of previously unrecognised tuberculosis (TB) and isolation of non-tuberculous mycobacteria (NTM) among HIV-infected individuals in a teaching hospital in Ghana. METHODS: Intensified mycobacterial case finding was conducted among HIV-positive individuals before initiation of antiretroviral therapy (ART). Data were collected on socio-demographic characteristics, medical history and TB-related signs and symptoms, and participants were followed for six months to determine treatment and vital status. Two sputum samples were obtained and examined for mycobacteria with smear microscopy, culture and Xpert MTB/RIF assay. NTM species were identified with the GenoType Mycobacterium CM/AS or sequence analysis of 16S rRNA gene. RESULTS: Of 473 participants, 60 (12.7%) had confirmed pulmonary TB, and 38 (8.0%) had positive cultures for NTM. Mycobacterium avium complex was identified in 9/38 (23.7%) of NTM isolates. Participants with NTM isolated were more likely to have CD4 cell count< 100 cells/μL (aOR 2.37; 95% CI: 1.10-5.14), BMI<18.5kg/m(2) (aOR 2.51; 95% CI: 1.15-5.51) and fever ≥2 weeks (aOR 2.76; 95% CI: 1.27-6.03) at baseline than participants with no mycobacteria. By six months, 76 (16.1%) participants had died; 20 (33.3%) with confirmed TB and 9 (23.7%) with NTM-positive culture. Mortality at six months was independently associated with TB diagnosis at enrolment (aHR 1.97; 95% CI 1.09-3.59), but not with NTM isolation after controlling for age, sex, CD4 cell count, BMI, prolonged fever and ART initiation. CONCLUSIONS: Intensified mycobacterial screening of HIV-infected individuals revealed a high burden of unrecognised pulmonary TB before ART initiation, which increased risk of death within six months. NTM were frequently isolated and associated with signs of poor clinical status but not with increased mortality.
OBJECTIVES: To assess the prevalence and clinical importance of previously unrecognised tuberculosis (TB) and isolation of non-tuberculous mycobacteria (NTM) among HIV-infected individuals in a teaching hospital in Ghana. METHODS: Intensified mycobacterial case finding was conducted among HIV-positive individuals before initiation of antiretroviral therapy (ART). Data were collected on socio-demographic characteristics, medical history and TB-related signs and symptoms, and participants were followed for six months to determine treatment and vital status. Two sputum samples were obtained and examined for mycobacteria with smear microscopy, culture and Xpert MTB/RIF assay. NTM species were identified with the GenoType Mycobacterium CM/AS or sequence analysis of 16S rRNA gene. RESULTS: Of 473 participants, 60 (12.7%) had confirmed pulmonary TB, and 38 (8.0%) had positive cultures for NTM. Mycobacterium avium complex was identified in 9/38 (23.7%) of NTM isolates. Participants with NTM isolated were more likely to have CD4 cell count< 100 cells/μL (aOR 2.37; 95% CI: 1.10-5.14), BMI<18.5kg/m(2) (aOR 2.51; 95% CI: 1.15-5.51) and fever ≥2 weeks (aOR 2.76; 95% CI: 1.27-6.03) at baseline than participants with no mycobacteria. By six months, 76 (16.1%) participants had died; 20 (33.3%) with confirmed TB and 9 (23.7%) with NTM-positive culture. Mortality at six months was independently associated with TB diagnosis at enrolment (aHR 1.97; 95% CI 1.09-3.59), but not with NTM isolation after controlling for age, sex, CD4 cell count, BMI, prolonged fever and ART initiation. CONCLUSIONS: Intensified mycobacterial screening of HIV-infected individuals revealed a high burden of unrecognised pulmonary TB before ART initiation, which increased risk of death within six months. NTM were frequently isolated and associated with signs of poor clinical status but not with increased mortality.
Authors: Isaac Darko Otchere; Adwoa Asante-Poku; Stephen Osei-Wusu; Samuel Yaw Aboagye; Dorothy Yeboah-Manu Journal: Int J Mycobacteriol Date: 2017 Jan-Mar
Authors: Catherine Okoi; Suzanne T B Anderson; Martin Antonio; Sarah N Mulwa; Florian Gehre; Ifedayo M O Adetifa Journal: Sci Rep Date: 2017-09-20 Impact factor: 4.379
Authors: David J Horne; Mikashmi Kohli; Jerry S Zifodya; Ian Schiller; Nandini Dendukuri; Deanna Tollefson; Samuel G Schumacher; Eleanor A Ochodo; Madhukar Pai; Karen R Steingart Journal: Cochrane Database Syst Rev Date: 2019-06-07
Authors: Adrienne E Shapiro; Jennifer M Ross; Mandy Yao; Ian Schiller; Mikashmi Kohli; Nandini Dendukuri; Karen R Steingart; David J Horne Journal: Cochrane Database Syst Rev Date: 2021-03-23
Authors: L H Chaisson; F Naufal; P Delgado-Barroso; H S Alvarez-Manzo; K O Robsky; C R Miller; J E Golub; A E Shapiro Journal: Int J Tuberc Lung Dis Date: 2021-06-01 Impact factor: 3.427
Authors: Stephanie Bjerrum; Frank Bonsu; Nii Nortey Hanson-Nortey; Ernest Kenu; Isik Somuncu Johansen; Aase Bengaard Andersen; Lars Bjerrum; Dorte Jarbøl; Anders Munck Journal: Glob Health Action Date: 2016-08-26 Impact factor: 2.640
Authors: Stephanie Bjerrum; Tobias Broger; Rita Székely; Satoshi Mitarai; Japheth A Opintan; Ernest Kenu; Margaret Lartey; Kennedy K Addo; Kinuyo Chikamatsu; Aurélien Macé; Samuel G Schumacher; Emmanuel Moreau; Maunank Shah; Isik Somuncu Johansen; Claudia M Denkinger Journal: Open Forum Infect Dis Date: 2019-12-21 Impact factor: 3.835